Updated:
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001629137, and its reported...
Overview
Global Blood Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001629137, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2022-02-23, it reported annual revenue of USD 194,749,000; net income of USD -303,091,000; total assets of USD 939,208,000 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Global Blood Therapeutics, Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001629137
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2021USD | $194.7M | -$303.1M | $939.2M | $684.7M | -$256.8M | |
| FY2020USD | $123.8M | -$247.6M | $724.0M | $494.8M | -$211.9M | |
| FY2019USD | $2.1M | -$266.8M | $796.1M | $302.2M | -$194.4M | |
| FY2018USD | — | -$174.2M | $617.6M | $275.4M | -$135.4M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 10-Q | 10-Q | ||
| 8-K | CURRENT REPORT | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| SC 13G | — | Form SC 13G | |
| 8-K | 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Global Blood Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.